Anna Kwilas

Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine

Anna Kwilas, Andressa Ardiani, Renee N. Donahue et al. · Journal of Translational Medicine · 2014 · 185 citations · Full text

IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas

Peter Kim, Anna Kwilas, Wenxin Xu et al. · Oncotarget · 2016 · 155 citations · Full text

Immune Regulation, Immunology, Nk Cells +20

The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells

Caroline Jochéms, Massimo Fantini, Romaine I. Fernando et al. · Oncotarget · 2016 · 140 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +24

Immune Consequences of Tyrosine Kinase Inhibitors that Synergize with Cancer Immunotherapy

Anna Kwilas, Renee N. Donahue, Kwong Y. Tsang et al. · Cancer Cell & Microenvironment · 2015 · 109 citations · Full text

Immune Consequences, Immunology, Immunoediting +19

Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway

Andressa Ardiani, Sofia R. Gameiro, Anna Kwilas et al. · Oncotarget · 2014 · 72 citations · Full text